Wet age-related macular degeneration involves leaks of fluid or hemorrhages under the retina and macula that cause distorting distortions to your central vision and eventual blind spots, necessitating immediate treatment.

Treatment for wet eye macular degeneration typically includes injecting medications that block vascular endothelial growth factor protein as well as detoxification, reduction of oxidative stress and cell activity stimulation to protect further vision loss.

Dr Larsen’s unique approach

The macula is a small area at the center of retina (the back layer of eye) composed of millions of light-sensing cells that help create sharp central vision. Age-related macular degeneration (ARMD), however, causes these cells to gradually break down, gradually blurring and distorting central vision gradually over time. More likely to affect older adults than people younger than 50 in developed nations, ARMD is one of the leading causes of irreversible visual loss.

Dr. Larsen takes an innovative approach to treating wet eye macular degeneration with cutting-edge technology and cellular medicine, employing cutting-edge techniques that have shown success at reducing laser treatments while maintaining vision. He works closely with his patients, educating them on how best to manage their condition by practicing healthy lifestyle practices such as eating more green leafy vegetables and fish, exercising regularly, maintaining normal blood pressure and weight regulation and engaging in lifestyle management education programs.

Wet AMD occurs when abnormal blood vessels (choroidal neovascularization) grow beneath the retina, leading to bleeding and fluid accumulation below the retinal pigment epithelium (RPE). This condition can eventually result in permanent vision loss; treatment typically includes injections of medicines into one or both eyes; although these injections might seem scary at first, most patients find them painless and well tolerated; these medicines block harmful signals which trigger growth of abnormal blood vessels and leakage of fluid between their walls – injections may be administered monthly; depending on each person’s response, treatment may vary accordingly.

Studies are ongoing for various new treatments for wet eye AMD. One such therapy is “dual action” inhibitors, which work by targeting molecules responsible for creating abnormal blood vessels in AMD. Unlike previous medications, dual action inhibitors may treat both dry and wet forms of the condition simultaneously – one such dual-action inhibitor is conbercept; recent research showed its efficacy at treating wet AMD by significantly improving functional vision in early stage disease cases.

Dr Larsen treats more than wet AMD; his expertise extends to treating other eye conditions and injuries such as glaucoma and diabetic retinopathy, among others. Certified by the American Board of Family Medicine and with clinical privileges at Sun River Health; previously completed fellowship training at Good Samaritan Hospital in New York he possesses vast experience with refraction/contact lenses/LASIK post-op care as well as co-management of ocular diseases.

Dr Larsen’s advanced technology

Dr Larsen and his team have built their practice upon the principle that patients come first. Together they strive to develop lasting relationships with all their patients, provide personalized care, and ensure every outcome of treatment meets patient satisfaction. Dr Larsen strives to become an ever-better physician and constantly works at perfecting his skills while staying abreast of advancements within his field.

As part of his hobbies, he enjoys spending quality time with his family. A passionate athlete himself, he particularly enjoys swimming and running – having competed in several Ironman Triathlons over time and been an active competitive swimmer for more than 30 years – Rutgers University and New York College of Osteopathic Medicine are among his alma maters.

He is both Board Certified Orthopedic Surgeon and Fellowship-trained Sports Medicine specialist, having been in private practice for over ten years. He treats a range of orthopedic conditions including injuries of the shoulder, elbow, arm and knee as well as ligament and cartilage reconstruction surgery, joint replacement procedures and nonsurgical methods of managing osteoarthritis.

Wet age-related macular degeneration (AMD) is a progressive eye condition that can result in serious vision loss. It occurs when abnormal blood vessels form under the retina’s choroid layer and leak fluid, lipids, and blood into it causing permanent damage to retina cells resulting in their degeneration causing vision impairment and eventually loss. Though AMD is a common condition it can be prevented with early diagnosis and appropriate treatment.

MaculaRevive uses cutting-edge technology and cellular medicine to slow the progression of AMD, and in many cases reverse existing damage. This approach addresses underlying factors like oxidative stress, inflammation and toxicity while optimizing cell function.

Signs of wet AMD include distorted straight lines or dark areas in your central vision. An Amsler grid can help detect changes to your vision quickly so you can seek medical assistance as soon as they arise.

Dr Larsen’s cellular medicine

Age-related macular degeneration (AMD) is a progressive eye condition, which results in the loss of central vision necessary for driving, reading, recognizing faces and viewing colors. AMD occurs when light-sensitive cells in the macula become damaged over time resulting in blurry or distorted vision; although common it can eventually lead to severe vision loss and blindness – making AMD the leading cause of legal blindness among Americans over 60 – with no known cure available yet.

Though its exact causes remain unknown, certain risk factors increase your risk for macular degeneration such as smoking, poor diet, high blood pressure and genetics. Therefore it’s essential that you consult your eye doctor about these risks in order to take measures to decrease them; also lifestyle modifications or medications are available that could help slow the progression of AMD.

Wet AMD, also known as Neovascular AMD, occurs when abnormal blood vessels form under the retina and leak fluid or blood, damaging retinal tissue and leading to permanent loss of central vision. Although less common than dry AMD, Wet AMD remains one of its more serious forms.

Intravitreal injections are the go-to remedy for wet AMD, usually without pain and usually well tolerated by their recipients. The medication contained within these injections blocks the signals responsible for abnormal blood vessel formation. Most individuals suffering from wet AMD require multiple monthly shots.

In difficult cases of wet AMD, photodynamic therapy or PDT may be added as part of the treatment strategy. PDT uses laser light to activate intravenous medications which travel through abnormal blood vessels to stop them leaking or bleeding; they absorb into these blood vessels and prevent further leakage or bleeding.

Dr. Larsen specializes in deep brain stimulation, gene therapy, cell transplantation and interventional MRI-guided surgery; movement disorders (Parkinson’s disease and essential tremor); auditory disorders (tinnitus); basal ganglia physiology; Huntington’s disease as well as clinical trials that aim at improving macular degeneration treatments.